v3.25.2
Blue Chip Growth Fund Annual Fund Operating Expenses - Class A C [Member] - Blue Chip Growth Fund
Aug. 31, 2024
Prospectus [Line Items]  
Fee Waiver or Reimbursement over Assets, Date of Termination <span style="color:#000000;font-family:Arial Narrow;font-size:8pt;">July 31, 2027</span>
Class A  
Prospectus [Line Items]  
Management Fees (as a percentage of Assets) 0.71% [1]
Distribution and Service (12b-1) Fees 0.30%
Other Expenses (as a percentage of Assets): 0.16%
Expenses (as a percentage of Assets) 1.17%
Fee Waiver or Reimbursement (0.03%) [2]
Net Expenses (as a percentage of Assets) 1.14%
Class C  
Prospectus [Line Items]  
Management Fees (as a percentage of Assets) 0.71% [1]
Distribution and Service (12b-1) Fees 1.00%
Other Expenses (as a percentage of Assets): 0.16%
Expenses (as a percentage of Assets) 1.87%
Fee Waiver or Reimbursement (0.01%) [2]
Net Expenses (as a percentage of Assets) 1.86%
[1] “Management fee” has been restated to reflect the contractual management fee schedule effective June 1, 2025.
[2] The advisor contractually agrees to reduce its management fee or, if necessary, make payment to the applicable class in an amount equal to the amount by which expenses of Class A shares exceed 1.14% of average daily net assets attributable to the applicable class. For purposes of this agreement, “expenses of Class A shares” means all class expenses (including fund expenses attributable to the class), excluding (a) taxes; (b) portfolio brokerage commissions; (c) interest expense; (d) litigation and indemnification expenses and other extraordinary expenses not incurred in the ordinary course of the fund’s business; (e) acquired fund fees and expenses paid indirectly; and (f) short dividend expense. The agreement expires on December 31, 2025, unless renewed by mutual agreement of the fund and the advisor based upon a determination that this is appropriate under the circumstances at that time. The advisor also contractually agrees to waive a portion of its management fee and/or reimburse expenses for the fund and certain other John Hancock funds according to an asset level breakpoint schedule that is based on the aggregate net assets of all the funds participating in the waiver or reimbursement, including the fund (the participating portfolios). This waiver equals, on an annualized basis, 0.0100% of that portion of the aggregate net assets of all the participating portfolios that exceeds $75 billion but is less than or equal to $125 billion; 0.0125% of that portion of the aggregate net assets of all the participating portfolios that exceeds $125 billion but is less than or equal to $150 billion; 0.0150% of that portion of the aggregate net assets of all the participating portfolios that exceeds $150 billion but is less than or equal to $175 billion; 0.0175% of that portion of the aggregate net assets of all the participating portfolios that exceeds $175 billion but is less than or equal to $200 billion; 0.0200% of that portion of the aggregate net assets of all the participating portfolios that exceeds $200 billion but is less than or equal to $225 billion; and 0.0225% of that portion of the aggregate net assets of all the participating portfolios that exceeds $225 billion. The amount of the reimbursement is calculated daily and allocated among all the participating portfolios in proportion to the daily net assets of each participating portfolio. During its most recent fiscal year, the fund’s reimbursement amounted to 0.01% of the fund’s average daily net assets. This agreement expires on July 31, 2027, unless renewed by mutual agreement of the fund and the advisor based upon a determination that this is appropriate under the circumstances at that time.